SMITH & NEPHEW PLC (NPW1.DE) Stock Price & Overview

FRA:NPW1 • GB0009223206

Current stock price

14.015 EUR
+0.07 (+0.5%)
Last:

The current stock price of NPW1.DE is 14.015 EUR. Today NPW1.DE is up by 0.5%. In the past month the price decreased by -3.44%.

NPW1.DE Key Statistics

1-Month Range13.7 - 15.9
Current NPW1.DE stock price positioned within its 1-month range.
Market Cap
5.949B
P/E
22.60
Fwd P/E
13.45
EPS (TTM)
0.62
Dividend Yield
2.46%

NPW1.DE Stock Performance

Today
+0.5%
1 Week
-3.14%
1 Month
-3.44%
3 Months
+1.19%
Longer-term
6 Months N/A
1 Year N/A
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

NPW1.DE Stock Chart

SMITH & NEPHEW PLC / NPW1 Daily stock chart

NPW1.DE Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to NPW1.DE.


Chartmill TA Rating
Chartmill Setup Rating

NPW1.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to NPW1.DE. NPW1.DE has an excellent profitability rating, but there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NPW1.DE Earnings

Next Earnings DateMay 6, 2026
Last Earnings DateMar 2, 2026
PeriodQ4 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

NPW1.DE Forecast & Estimates

24 analysts have analysed NPW1.DE and the average price target is 16.68 EUR. This implies a price increase of 19.02% is expected in the next year compared to the current price of 14.015.

For the next year, analysts expect an EPS growth of 13.3% and a revenue growth 5.58% for NPW1.DE


Analysts
Analysts75.83
Price Target16.68 (19.02%)
EPS Next Y13.3%
Revenue Next Year5.58%

NPW1.DE Groups

Sector & Classification

Index Membership

NPW1.DE Financial Highlights

Over the last trailing twelve months NPW1.DE reported a non-GAAP Earnings per Share(EPS) of 0.62. The EPS increased by 52.3% compared to the year before.


Income Statements
Revenue(TTM)6.16B
Net Income(TTM)625.00M
Industry RankSector Rank
PM (TTM) 10.14%
ROA 5.98%
ROE 11.82%
Debt/Equity 0.62
Chartmill High Growth Momentum
EPS Q2Q%70.1%
Sales Q2Q%7.38%
EPS 1Y (TTM)52.3%
Revenue 1Y (TTM)6.09%

NPW1.DE Ownership

Ownership
Inst Owners71.25%
Shares424.49M
Float423.76M
Ins Owners0.11%
Short Float %N/A
Short RatioN/A

About NPW1.DE

Company Profile

NPW1 logo image Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 16,988 full-time employees. The firm is engaged in developing, manufacturing, marketing, and selling medical devices and services. The company is focused on the repair, regeneration, and replacement of soft and hard tissue. The firm's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.

Company Info

IPO: 1951-08-13

SMITH & NEPHEW PLC

Building 5, Croxley Park, Hatters Lane

Watford HERTFORDSHIRE GB

Employees: 17349

NPW1 Company Website

NPW1 Investor Relations

Phone: 4401923477100

SMITH & NEPHEW PLC / NPW1.DE FAQ

What does SMITH & NEPHEW PLC do?

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 16,988 full-time employees. The firm is engaged in developing, manufacturing, marketing, and selling medical devices and services. The company is focused on the repair, regeneration, and replacement of soft and hard tissue. The firm's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.


What is the current price of NPW1 stock?

The current stock price of NPW1.DE is 14.015 EUR. The price increased by 0.5% in the last trading session.


What is the dividend status of SMITH & NEPHEW PLC?

SMITH & NEPHEW PLC (NPW1.DE) has a dividend yield of 2.46%. The yearly dividend amount is currently 0.33.


What is the ChartMill rating of SMITH & NEPHEW PLC stock?

NPW1.DE has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


What sector and industry does SMITH & NEPHEW PLC belong to?

SMITH & NEPHEW PLC (NPW1.DE) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


How is the valuation of SMITH & NEPHEW PLC (NPW1.DE) based on its PE ratio?

The PE ratio for SMITH & NEPHEW PLC (NPW1.DE) is 22.6. This is based on the reported non-GAAP earnings per share of 0.62 and the current share price of 14.015 EUR.


What is the employee count for NPW1 stock?

SMITH & NEPHEW PLC (NPW1.DE) currently has 17349 employees.